Format

Send to:

Choose Destination
See comment in PubMed Commons below
Expert Rev Anti Infect Ther. 2008 Oct;6(5):685-711. doi: 10.1586/14787210.6.5.685.

Plasmid-mediated quinolone resistance.

Author information

  • 1Service of Microbiology, University Hospital Marqués de Valdecilla, and Department of Molecular Biology, University of Cantabria, Santander, Spain. lmartinez@humv.es

Abstract

The first plasmid-mediated gene involved in quinolone resistance (qnrA1) was reported in 1998. It codes for a pentapeptide-repeat protein that protects type II topoisomerases from quinolones. Additional related plasmid-mediated genes (qnrB, qnrS and qnrC) and chromosomal homologs of them have also been discovered. Two other plasmid-mediated resistance mechanisms were later reported: modification of quinolones with a piperazinyl substituent by the acetyltransferase Aac(6)-Ib-cr and active efflux by QepA, a pump related to the major facilitator superfamily transporters. These genes have a wide geographical distribution (essentially in enterobacteria), although their real prevalence is only partially known because of the difficulty of phenotypic detection of this type of resistance. Although these mechanism cause low-level resistance, they favor and complement the selection of additional mechanisms of resistance.

PMID:
18847406
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Write to the Help Desk